Views on future trials
We asked parents if they would consider involving their children in future medical research if the opportunity was offered. All parents said that they would ‘consider it’. Some parents had already enrolled their children in more than one trial.
However, as with their previous decision about enrolling their children, parents said they would be considering the risk and benefit to their children, the demands of the trial in terms of time and the wider benefits of the trial for other children and medical science. They said they would want good, clear information about the trial and would want to be sure their children were happy to take part and understood what was expected of them. They would want to be aware of any potential side effects, and that any treatment such as medication was safe and previously tested. Knowing that a drug had been tested and safe for their children to take was important to all parents. The majority of parents said that they would not enrol their children in trials if the treatments or drugs had not been previously tested for safety.
view profile
Now Playing
Even though Ruth had decided not to enrol her son in a swine flu vaccine trial, she would certainly consider another clinical trial in the future.
view profile
Displayed below
Tina says that having good information and being able to ask questions would certainly make a difference to any future decisions about enrolling her children in a trial.
view profile
Profile Info
- Age at interview:
- 38
- Sex:
- Female
- Background:
- Ruth is married and mother of George aged 22 months. Ruth works full time in Higher Education and describes herself as White British. Ruth declined to enrol her son on a swine flu vaccine trial.
I think I mean it wouldn’t dissuade me just because I said no to this particular trial I don’t think it would dissuade me from taking part in other clinical trials. If I thought they were of either benefit to the greater good or whether they were of particular benefit to me or my family but I think I’d still go through the same decision process, I’d still source out the information and make sure I was happy with the decision before I went through with anything really but I think that’s more me rather than, you know, the fact it being a clinical trial.
view profile
Profile Info
- Sex:
- Female
- Background:
- Tina is married and mother of three children aged 9, 11 and 18 years. Tina is a self-employed Management Consultant and describes herself as White British.
Yes, definitely. I mean definitely, I mean I thought the information was very good. I think that there is the opportunity to ask questions. I thought that you know if you like the, the patter that we were given about the origin of the vaccine, the way that it had been used up till then and the potential risks were very clear. And I, and I also felt that had we wanted to explore that in any more detail or ask more questions, then the medical staff would have been happy for that and would have been able to answer questions. So yes, I mean I think it is a yeah, it was a very positive thing.
However, as Alison suggests, having good information should also include the possibility of a trial showing that a new treatment has no beneficial effect. Alison refers to a trial that her son took part in during his stay in neonatal care. The doctors and nurses were very positive about the trial and so when the trial showed no beneficial effect of an antibiotic to reduce sepsis in very premature babies, it was slightly disappointing. This is important and researchers may need to consider how to manage parents’ expectations at the beginning of a trial.
view profile
Profile Info
- Age at interview:
- 39
- Sex:
- Female
- Background:
- Alison, aged 39 years is White British, works part time as a music teacher and lives with her husband and three children. Her son was diagnosed with Intrauterine Growth Restriction around 22 weeks. Alison gave birth to her son at 30 weeks; he weighed 2lbs.
Yes, I would. I, I think I’m slightly, not cynical, that’s the wrong word, but maybe slightly more pessimistic, or maybe that’s a bit too strong a word, about outcome of things now, and just think, “Well, we could take part in something that might show that it’s pointless.” And, and that’s worthwhile in itself, but not always to think that everything you do is just suddenly going to have this massive knock-on effect in medicine and open lots of doors. Which sometimes things do. But just be a bit more realistic I think or, you know.
It might benefit?
Yes, it might, yes.
And having that explained maybe at the beginning?
Yes. It’s difficult when you’ve never experienced a trial before, isn’t it, to kind of know where things go and how they go and, and, and what they do? But, yes, I think that, that would be helpful to know, you know, “Sometimes we don’t find out what we set out to do. Or sometimes we have to stop a trial.” You know, just, maybe that’s something we could have researched more actually and had a bit of a bigger picture of. You know, you just, and again you just, it’s you and them. Which sounds awful, and that’s not how it should be. And you want to make that gap as small as possible. But it, you know, it puts you at a distance, because actually you, you have no control over it whatsoever. Which comes back to trust again, which I think is, is key. Yes, it’s the key.
Randomised trials are done when we don’t know which treatment is best, in other words when the relative merits and disadvantages of different treatments are uncertain. It is important to realise that, on average, new treatments are as likely to turn out worse as they are to turn out better than existing treatments. This means that, going in a trial, everyone, regardless of which of the treatment groups the computer allocates them to, must have similar chances of a good outcome. If, in spite of the treatment uncertainties that the trial has been designed to address, people would strongly prefer one of the treatments being compared, they should not volunteer for the trial.
In addition to sufficient information and being able to ask questions, the majority of parents felt it was important to include their children in the decision where possible.
view profile
Now Playing
Steve says it is his son's choice to take part, or not, in a trial, although he hopes that his son knows he wouldn't put him forward for a trial if it could cause him any unnecessary harm or discomfort.
view profile
Now Playing
Lena would consider other vaccine trials for her children if there was sufficient information and the vaccines had already been trialled. She would also listen to her children to make sure they were happy to take part.
view profile
Now Playing
Jane would consider other trials for her daughter if they could help other children with diabetes, but only if her daughter wanted to take part.
view profile
Now Playing
Taking part in clinical trials helps improve treatment, but his son would have the final decision.
view profile
Profile Info
- Age at interview:
- 49
- Sex:
- Male
- Background:
- Steve took part in Cohort Asthma Study after the birth of his son. Study continues and his son has now taken part in the second stage of the study to look at allergies.
I would like to think that any trials that involved possibly days, mornings, afternoons, even overnight at a hospital that by the time we’re at that stage they’re freely giving you the information, and we know roughly that yes, things can go wrong, things don’t always go according to plan. But we, I would like to think that isn’t the norm. Yes, we all know that things can go wrong and it is just bad luck. They’ve not gone out of their way to make you stay in hospital even longer because it’s not what they’ve wanted you there for. So yes, I would like to think that providing they came to me with all the information that I think is relevant they could answer all my questions, then I would be saying to Jhon, “I think go for it” and that he would. I would like to think he’d say yes, but I can’t make him. I don’t have that right, even though I’m his Dad. And, he’s a minor. I think he’s old enough, maybe too wise, but at the end of the day the choice is his. And I’d like him; I’d like to think that he knows that I wouldn’t put him forward for anything that was going to cause him unnecessary discomfort.
view profile
Profile Info
- Age at interview:
- 44
- Sex:
- Female
- Background:
- Lena, aged 44 years is White British and married with three children ages 11, nine and two years. Lena works part time as a child-minder. Lena consented for her youngest child to receive the swine flu vaccine as part of a clinical trial.
Yes, with as much information that we had yeah. We would want as much information. I mean I say yes, but you would obviously still look into it. It’s not something you, you know you just say oh yes blindly. But we would consider it again, yes.
If it had been in the early stages, when they really didn’t know much, and they hadn’t trialled it out with children, then I don’t know that we would have, because she was so, when they’re so young you’re making that decision for them, it would have, yeah I don’t that I would have necessarily have done it the same way really.
Well if the child was old enough to communicate, so just say if it had been my son who’d gone for the trial. And if he at any point had said, “I don’t want to do this.” Then, then we would have stopped really. So I think once you get to about four or five. When they can tell you they don’t want to do something, even if it’s because they don’t like the colours of the nurse’s uniform, it could be something really trivial, or, they don’t like the hospital or something, then you would stop. Because there’s no point in putting your child through distress just because you feel that, you know, even if you tried to reason with them, no I wouldn’t do that, no.
view profile
Profile Info
- Age at interview:
- 41
- Sex:
- Female
- Background:
- Jane, aged 41 years, is White British and works full time in Primary School Education. She lives with her husband and their daughter who is 13 years of age. Their daughter was diagnosed with Juvenile Diabetes at the age of 11.
Yes, I would consider anything again, yes, to help other people, definitely.
And what about if it was like a treatment?
It would, yes, I would consider anything. And I think, you know, with diabetes a lot of it is about progressive treatment and trying to change things. And, you know, we manage on the existing regime, but we’re always reading about stuff. So if that needed people to, and I could make a decision and had enough information, then I would consider it. Obviously, with Saskia’s views on board.
Yes, yes, yes. I don’t know how it would be if it was something, you know, because diabetes is, is, although the actual illness, you know, they have to inject themselves, they have to… So it’s all very well somebody saying, “You have to do it” but they have to do it, don’t they? It’s their body. So if it was something like that and she didn’t want to do it, then I’d have to really consider. Even if I felt that it was going to help other people and maybe help us in, sometime in the future, but she didn’t want to do it, then we probably wouldn’t do it. I think it’s bad enough having their illness as it is without being forced to do something you don’t want to do, that you don’t need to do. If you don’t need to do it, then her view would be, “Why?” But she might, she might take a pragmatic view. She, you don’t know unless you’re faced with it, do you? She might think, “Oh, well, that might help me in the future. So if I don’t do it and nobody does it, we won’t get a better way of dealing with the insulin or whatever.”
view profile
Profile Info
- Age at interview:
- 29
- Sex:
- Male
- Background:
- Paul is aged 29 years, is White British, a full time homemaker and lives with his son aged 8 years.
And is there a time when you might stop your child taking part in a clinical trial?
Well, the, the only time I’d stop it is if my son, my son obviously didn’t want to. And that, that would be the only time. Because obviously if he doesn’t want to do it I can’t force him to. It’s, it’s his decision. But, you know, obviously if it’s going to help him, I couldn’t see why he wouldn’t.
And would you take part in another one as your son gets older?
Well, yes, to see, yes, because obviously, obviously when he’s older, because he’s only like, obviously he’s, well, he’s 8, or would have been like 6, well, 6½ say, so obviously when he gets older it’s to see the change in the way everything’s gone. So, yes, I would like him to do it when he’s older. Because that’s how, you know that’s how the, the doctors learn and, you know, that’s how they work it like. Because from when he was a, like 6½ and when he next gets it done, how so much is done on it. Like he’s, obviously he’s had to have more insulin, he’s had to have less, certain things like that. You know, it all, it all helps.
Most parents we talked to would consider other trials if there was minimal discomfort to their children and if there were benefits for their children’s health. For trials that were more invasive such as taking medication or required lots of tests, some parents said they would like to find out from other trial participants what their experience had been before making a decision to enrol their children.
view profile
Now Playing
Talking to other trial participants is something Nikki and Chris would like to do if they were to consider any future trials that required new or more invasive treatments for their daughter.
view profile
Now Playing
John has enrolled his daughter in various trials and would consider other trials depending on how intrusive they were.
view profile
Now Playing
Linda would consider another trial especially if it might benefit her daughter.
view profile
Profile Info
- Age at interview:
- 38
- Sex:
- Male
- Background:
- Chris aged 51 and Nikki aged 38 are White British, married with four children ages 8, 6, 3 and 10 weeks. Chris is a retired fire office and Nikki is a housewife. Their eldest daughter has severe asthma and a severe adrenal deficiency.
Nikki' I think it, I think it would depend. I think we would get, gather all the information is what we tend to do [isn’t it?] and say, you know, “What’s it about? Why, why are we doing it? How invasive is it?” And, you know, for the likes of Sarah you –
Chris' What are the national and personal benefits? What’s the broad benefit and what’s our benefit?
And again we would talk to Sarah if it was about Sarah doing a trial. Because, you know, you’ve got to. You can’t just say, “Yes, they’ll do it” and they then get frightened or it’s something that they don’t want. Again we would gather all the information and then speak to Sarah and say, “What do you think?” And, you know, and again if it’s invasive, well, how can you make that as pleasant as possible and, you know, not frightening or anything for the child?
Chris' And I think if you were going to be involved in a trial that was more invasive, and there are some, you know, your child’s got an illness and they come up with a, you know, “It’s invasive but we might find something out” I think then I would want, would probably really like to speak to somebody who’s been involved in something similar or look at something like this. It would really be a bit more relevant. Because we didn’t see, we knew she didn’t like her blood test, but we had both had them and seen her have them, so we both, we knew it was unpleasant but not major; something that could be dealt with even if it involved a little bit of upset. Whereas if it was more major than that and it easily could be, then I think we would have thought harder and looked into it more. Probably questioned where the results were going more and what the likely outcome was more than we did. Because in this case we saw it was a test for Sarah that gave us information and that, you know, the worst thing was going to be half an hour’s upset. Had that meant that she was going to be wearing something that was uncomfortable for weeks or taking any sort of medicine or drug, I think we would have spent longer and harder thinking about it.
view profile
Profile Info
- Age at interview:
- 35
- Sex:
- Male
- Background:
- John is married with four children. John left full time employment to become a full time carer to his daughter Chloe who has cerebral palsy and global developmental delay and his remaining children. John describes himself as White British.
Yeah, yeah, but obviously depends what it is. You know, like I said earlier if we’re looking at taking a lung then you know whatever then that’s a different kettle of fish. But as long I guess as long as it’s minimally intrusive not likely to have any have any detrimental impact or effect on her then yeah, no problem.
view profile
Profile Info
- Age at interview:
- 43
- Sex:
- Female
- Background:
- Linda, aged 43, is White South African, works part-time as a Staff Nurse, is separated and mother of three children; all born in the UK; ages 7, 9 and 15 years. Linda's youngest child was diagnosed with a heart condition 12 hours after she was born.
And now, that’s a, I mean because at the hospital where she’s seen for her heart, it’s sort of sister hospital does trials for nuts and that’s something I would take her for. They haven’t offered it to her yet but that’s a clinical trial where they do that where they rub a bit of nut on the lip and you have to, it’s all done in intensive care under very careful monitoring, and then systematically increase over a few days the exposure to nuts and that’s meant to, they have said that they probably wouldn’t offer it to her because she’s allergic to three kinds of nuts so that would be, you know, but then might peanuts which is the most severe allergy they might do. And that’s something I would consider but that would purely be for her benefit [laughter] yes, you know, that’s yes so that would be nobody else would benefit from that, that would just be her, you know.
Contributing to medical knowledge and helping other children were also important to parents although some parents were unconvinced about their children taking part in randomised placebo controlled trials. (See ‘Understanding allocation (randomisation) to a treatment comparison group’ and ‘Why do we have clinical trials in children and young people’ for explanations about different trial designs.)
view profile
Now Playing
Vicky would consider other trials if it would help her daughter and other children with diabetes and other long-term conditions.
view profile
Now Playing
Lucinda supports research and was quite surprised that childhood migraine hadn't been researched.
view profile
Now Playing
Although Catherine is supportive of clinical trials, she is less convinced about enrolling her son in randomised placebo controlled trials.
view profile
Profile Info
- Age at interview:
- 39
- Sex:
- Female
- Background:
- Vicky is aged 39 years, is White British, married with three children all under 12 and has full-time employment. Her 9 year old daughter was diagnosed with diabetes at the age of 2.
There would, there would be a point. But I think it’s difficult to know what that point would be. Because I mean obviously a change in her treatment which may have direct effect on her health, then I think we’d sort of have to look into it more and understand more about, you know, the development of that particular drug, say, beforehand and how far they’d got and whether it was likely to be successful and, and things like that. I think, yes, anything which would have an impact on her health, then we’d consider. And I mean I don’t know what the point would be where we would say no, because obviously the only way that you get to see whether new things work is by trialling them. But obviously it’s that balance, isn’t it? Between letting somebody else do it.
Yes, that is something that we’ve thought of. And I mean you always, when you hear about a new treatment you always think, “Oh, you know, when will that be available? When can we start doing that?” But obviously it takes a long time for that to happen. And so I think, yes, if anything came up like that then we would consider.
Yes, yes. So, yes, if you, if you take part in it you may only be helping other people and not yourself. But I suppose people who have a long-term condition perhaps understand that even that is still worthwhile doing, you know, because they understand what it’s like to live with that condition. So, you know, even if they’re helping other people. But again there’s got to be that balance between helping other people and it being detrimental to you. So, yes, I think those are the considerations.
view profile
Profile Info
- Age at interview:
- 37
- Sex:
- Female
- Background:
- Lucinda, aged 37 years, is a single mother to her son Toby aged 10 years. Lucinda describes herself as White British as works fulltime in the legal profession.
Depending on what it was, yes. I don’t have a problem with research. I think it’s a really important part; it’s a major part actually in science. And I know through my own work, collecting data is just a must. So whatever can help in the future, I think. And I was quite surprised actually when we were told that childhood migraine hadn’t been researched. I think if it’s been about for as long as it has, I was, I was really quite shocked that it hadn’t. I thought it would have been a lot more advanced. But I do understand that there isn’t much they can do. Because, as we were told, as, as Dr explained to Toby, there isn’t physically anything wrong with the brain, it’s just the cells. So there isn’t much they can do.
view profile
Profile Info
- Age at interview:
- 27
- Sex:
- Female
- Background:
- Catherine is married and mother of their first child Mikey. Until taking maternity leave Catherine worked full time as a Social Worker and describes herself as White British. Catherine was invited to enroll her son on two clinical trials.
One of the studies I was going to be, participate, in before we knew about my genetic problem was a progesterone trial when you when you got pregnant you’d be given progesterone. My issue with that really was I I’d had three miscarriages by then and my issue with that was that if I was in the, the placebo group I wasn’t getting the progesterone and when you’re talking about whether it’s going to help you keep a baby that’s sort of a huge, it’s not like you’re taking a you’re taking a drug to see if you think you know does it work against aspirin. It’s like if I have this drug I might keep the baby and if I don’t I might lose it and if I’m in the placebo group I won’t know and I, and that would have been a really tough call to make. As it was I wasn’t accepted because I found I had an underlying condition. So I guess it all depends, it’s like if you were saying if he had cancer and you wanted to give him chemotherapy or a placebo group why would you want your child to not have the treatment because you were in the placebo group and you don’t know and then it it’s really tough isn’t it. I guess you really have to think about each thing as you come up to it; it’s not something you can just say we’d be in or we wouldn’t be in. It would depend on the circumstances.
Most parents we talked to would support their children if they wanted to take part in trials in the future, although they also recognised that making a decision for yourself and making a decision for your child is a very different thing.
view profile
Now Playing
Even though Julie's son was not eligible to take part in a trial, she would consider another trial, depending on the discomfort to her son, the personal benefits and the benefits to other children.
view profile
Now Playing
Julie would support her son if he wanted to take part in a trial in the future, and explain that it may not have any immediate personal benefit but may help other people and medical knowledge.
view profile
Displayed below
Taking part in other trials would depend on the benefit for Rachel's children and the benefit to society.
view profile
Profile Info
- Age at interview:
- 45
- Sex:
- Female
- Background:
- Julie aged 45 years lives with her husband and son aged three months. Julie works in higher education and is currently on maternity leave. Julie volunteered to take part in a clinical trial and was turned down.
Yes, yes suitable things. I think for my baby I would be even less inclined to do things which required physical discomfort for him, for example taking blood tests and things like that. I’ve volunteered to do that myself with some of the studies I’ve done. When I had an MRI I had to have two cannulas inserted, you know, which is, which is mildly uncomfortable. But I would, I would think twice before I volunteered the baby for that kind of thing. I think in his case there would have to be a much more direct benefit for him for example to have blood taken than just the warm fuzzy feeling you get from helping out with research, which, which, might with research which might ultimately not have a direct impact on your own health or wellbeing.
So it’s quite a different thing isn’t it to volunteer yourself to take part than to volunteer your child to take part?
Yes I think so yes and I know that the medical and healthcare that brought him into this world and is keeping him healthy is important and it’s very often research based and so on. But I think I have a duty of care to him to think carefully about what I might be subjecting him to. And of course in the case of my baby I would also have to discuss it with his father before I volunteer him for anything. But for example I’ve I’ve volunteered him for the local university to do some psychology studies which are non invasive and usually they’re actually fun for the baby involved. Yes, yes. No I think if it was going to be uncomfortable for him, I think I’d have to be persuaded of the benefit, for example if he had a rare blood group for example and they were, there were few people they could call on for a trial then I would be more persuaded to allow a little bit of discomfort for him if it was going to be of very great benefit for a large number of people.
view profile
Profile Info
- Age at interview:
- 45
- Sex:
- Female
- Background:
- Julie aged 45 years lives with her husband and son aged three months. Julie works in higher education and is currently on maternity leave. Julie volunteered to take part in a clinical trial and was turned down.
I think I’d encourage my older children to take part in trials if they wanted to and I think I’d explain that they wouldn’t necessarily be any personal benefit to them but you don’t know if what you’re going to do is to benefit somebody else in the future. So yes I would, I would encourage them to take part and to think of themselves as citizens with a, with a contribution to make.
view profile
Profile Info
- Age at interview:
- 35
- Sex:
- Female
- Background:
- Rachel is 35 years of age, White British, and lives with her husband and their three children aged three, five and seven years. Rachel works part time as a Research Fellow and trial manager for a Clinical Trial.
It would depend what the trial was for as well. So it’s not just the level of risk. It would be risk-benefit really. So it would be whatever benefit, and not, I don’t just mean that to my child, but I mean sort of society benefit as well, what the overall benefit would be. Obviously the level of risk is relevant as well. And again I think it would just depend so much on what the trial was and what it was for.
Having good rapport with the research team, doctors and nurses involved in the trial and treatment of their children were also important factors in making parents feel positive about future research opportunities.
view profile
Profile Info
- Age at interview:
- 38
- Sex:
- Male
- Background:
- Chris aged 51 and Nikki aged 38 are White British, married with four children ages 8, 6, 3 and 10 weeks. Chris is a retired fire office and Nikki is a housewife. Their eldest daughter has severe asthma and a severe adrenal deficiency.
Nikki: Yes, but as I say, the number from the nurse and then to the consultant that she referred us to, that, you know, that we’ve got mobile numbers, emails, everything. You know, they’ve been so approachable and nothing’s been any trouble. So, you know, we were phoning that nurse most days [weren’t we?] in between going to see the consultant and that. And, and she was great. It never felt like, you know, “Oh, it’s them again.” It was, “Right, okay, what’s wrong?” Even when we repeated questions or I’d found, you know, because she said, “Don’t go on the Internet and, you know, looking at Wikipedia for adrenal insufficiency, because you’ll get terrified.” But you can’t help it. You’re going to do that. You know, it, it’s like this site. If I’d have known that this site was there it would have helped us, wouldn’t it? Just to, to have that realism that somebody going through it and come out the other, the other end. Because you, you just, our world just went to pieces, didn’t it?
Chris: The continuity of the nurses from the beginning of the trial through to today, because it was that very same nurse that mentioned this process. So that, I think that, and once you’ve started again, she was in yet another trial the other day, when we went in the last time, which is to look at absorption rates from the inhaled steroid and, and deterioration from when you take it. And when we went in for one of her asthma reviews they actually took a urine sample and asked for the exact time of hydrocortisone medicine and measure and inhaled steroid time, quantity, and would they’d be looking at, for a tailing off graph, and we were trying to do that. But of course once you’ve started you tend to be more open to others, particularly if they’re what you might call non-invasive procedures, you’re more open, because you think it all helps to build a picture up.
And again Sarah knew the nurse, so she was happy that, you know, she’s helping more people now because she’s done this. And, as you say, it wasn’t invasive. It, you know, it’s over like that, isn’t it?
view profile
Now Playing
Sandra hadn't come across clinical trials or medical research before, but she wanted to take part in the study to help advance knowledge about juvenile dermatomyositis and would consider other research and clinical trials in the future.
view profile
Now Playing
It is important that families who want to contribute to increasing medical knowledge have the opportunity to take part in clinical trials says Dr William van't Hoff.
view profile
Profile Info
- Age at interview:
- 46
- Sex:
- Female
- Background:
- Sandra aged 46 years is a full time housewife. She has five children. One of her daughters was diagnosed with juvenile dermatomyositis, a rare condition that affects children under the age of 18 years.
If it had been a change of, a different treatment, or, wanting to try a different treatment for her, would you still have been quite as keen?
Yes, I think so. I totally trusted the doctors and, you know I believed that they knew what was best for my daughter and they were all for getting her well. So if they’d, you know, recommended, I mean she did end up having another treatment as well, which was, I’m not sure, immunoglobulins or something or other, which was a pretty new treatment, tested on children with JDM (juvenile dermatomyositis). She had that as well. And then she also had another treatment, which was for side effects of the steroids, because it started to affect her bones, thinning bones. So she had Promiginate, which they give to old ladies for osteoporosis. But I guess I just trusted them and let them give what I thought was best for [daughter], you know. Because they’re the best people to help, aren’t they?
I mean would you, you know, did you ever think, “Well, actually I don’t want to do it” at all?
What, the trial? No, no, never, no. It was just a instinct, gut reaction, “Yes, I’m happy for that.” Because I knew that no bad would come of it, you know. It was all confidential. And I thought even some good may, may come of it. There’s a good chance that some good may come of it. Because in the medical profession, and science and stuff like that, they’re learning things every day, aren’t they? So they’re bound to learn something from those, these results, bound to. And to me that’s good, you know. Anything they can learn about JDM is brilliant, you know, because it’s going to help kids in the future who get it.
Do you, do you support clinical trials in general?
It’s not something that I’ve ever thought about, clinical trials, at all. Because I’ve got five children, [daughter] is my fourth, and none of my other kids have ever been ill or anything like that. And, you know, I’m just a housewife. So clinical trials had not even entered my radar, you know, until my daughter.
What do you know about clinical, if you were to explain it, how would you explain your understanding of clinical trials, as that was your first experience?
I don’t, don’t really know. A lab, a whole load of blood results, a whole load of CMAS scores. And, you know, I really don’t know. I don’t have a clue. I don’t understand how it works. I, I didn’t even think of that. I just thought if it can help, then that’s it.
view profile
Profile Info
- Sex:
- Male
- Background:
- Dr William van't Hoff is Co-Director Medicines for Children Research Network.
Studies show that most families and young people would like to be told about research that’s relevant to their condition or their family. But often health professionals, doctors or nurses are reluctant to place an extra burden of research on a family that may have a lot of other worries about the disease or their child at that time. Indeed there are studies coming through now which indicate that families who wanted to take part were not given that opportunity. It’s really important that families and young people who want to know or are interested if there are research opportunities to improve their care speak up and indicate to their doctors and other health professionals that they are interested in hearing about the research. It doesn’t mean they have to take part, but they may well want to know what’s going on and think about the opportunity to participate in that study. And doctors and nurses need to recognise that families are increasingly interested in hearing about the research opportunities and giving, being given their own choice to decide whether or not they can participate.
Last reviewed September 2018
